King Andrew James bought JBIO
February 12, 2026 · Form 4 insider transaction
King Andrew James bought 247,500 shares of Jade Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
247,500
Price
$0.00
Total value
N/A
InsiderKing Andrew James
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 12, 2026
Filing dateFebruary 13, 2026
Shares owned after247,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of the Issuer's common stock, one quarter of which will vest on February 15, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.